Holen Sie sich die Stockscreener-App
12.80
1.27%
0.16
Handel nachbörslich:
12.55
-0.25
-1.95%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.64
Offen:
$12.7
24-Stunden-Volumen:
290.06K
Relative Volume:
0.72
Marktkapitalisierung:
$563.31M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-22.86
EPS:
-0.56
Netto-Cashflow:
$-20.63M
1W Leistung:
-8.38%
1M Leistung:
-2.74%
6M Leistung:
+111.92%
1J Leistung:
+117.69%
1-Tages-Spanne:
$12.55
$13.01
1-Wochen-Bereich:
$12.18
$14.15
52-Wochen-Spanne:
$5.55
$15.90
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AXGN | 12.80 | 563.31M | 159.01M | -21.72M | -20.63M | -0.56 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 8.1% in October - MarketBeat
Axogen Inc (AXGN) Shares Down 5.01% on Nov 12 - GuruFocus.com
AxoGen's SWOT analysis: nerve repair firm's stock faces growth hurdles By Investing.com - Investing.com UK
AxoGen, Inc. (NASDAQ:AXGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Recent 9.2% pullback isn't enough to hurt long-term Axogen (NASDAQ:AXGN) shareholders, they're still up 152% over 1 year - Simply Wall St
Axogen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Creative Planning Has $418,000 Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen Reports Strong Q3 2024 Revenue Growth - Yahoo Finance
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Yahoo Canada Finance
Axogen Reports Strong Q3 Growth and FDA Progress - TipRanks
Axogen Inc earnings beat by $0.06, revenue topped estimates - Investing.com
AxoGen Q3 2024 Earnings Preview - MSN
First Light Asset Management, LLC Increases Stake in Axogen Inc - GuruFocus.com
SYK: 3 Medical Devices Stocks Poised for Solid Growth - StockNews.com
AxoGen (NASDAQ:AXGN) Trading Down 11.2%Here's Why - MarketBeat
Analysts Predict How High Axogen Inc (AXGN) Will Go. - Stocks Register
Axogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AxoGen: Q3 Earnings Snapshot - Marketscreener.com
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update - GlobeNewswire
Axogen stock soars to 52-week high, hits $15.24 amid robust gains - Investing.com Australia
AxoGen (NASDAQ:AXGN) Hits New 12-Month HighHere's Why - MarketBeat
Axogen Inc (AXGN) Shares Up 3.84% on Nov 4 - GuruFocus.com
AxoGen (AXGN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
When (AXGN) Moves Investors should Listen - Stock Traders Daily
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Semanteon Capital Management LP Acquires New Position in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 - GlobeNewswire
Axogen (STU:LT3) Cyclically Adjusted PS Ratio : 4.57 (As of Oct. 23, 2024) - GuruFocus.com
South Korea Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
Colombia Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
nVerses Capital LLC Acquires Shares of 4,000 AxoGen, Inc. (NASDAQ:AXGN) - Defense World
(AXGN) Investment Analysis - Stock Traders Daily
FY2028 EPS Estimates for AxoGen Cut by Leerink Partnrs - Defense World
AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains? - MSN
Axogen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic? - Simply Wall St
Leerink Partnrs Has Weak Outlook for AxoGen FY2028 Earnings - MarketBeat
AxoGen (NASDAQ:AXGN) Stock Price Down 4.3%Should You Sell? - MarketBeat
Exchange Traded Concepts LLC Reduces Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen Inc (AXGN) Stock Price Down 3.7% on Oct 17 - GuruFocus.com
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen stock soars to 52-week high, hits $15.12 amid robust gains - Investing.com Australia
StockNews.com Upgrades AxoGen (NASDAQ:AXGN) to “Buy” - Defense World
AxoGen (NASDAQ:AXGN) Rating Increased to Buy at StockNews.com - MarketBeat
Peripheral Nerves Injury Operative A Game Changer for Global Finance Forecast-Neurorrhaphy, Nerve Grafting, Axogen, Inte – IndiaPolitics.com - IndiaPolitics.com
Peripheral Nerve Injuries Therapeutic Market Business Standards – AxoGen, Inc., Stryker, Baxter International - Cauverynews
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Millennium Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Stake Cut by Millennium Management LLC - MarketBeat
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):